瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02179 瑞科生物-B

休市中 12-05 15:56:13

5.500

+0.050

+0.92%

最高5.620	最低5.500	成交量5,000
今开5.620	昨收5.450	日振幅2.20%
总市值26.56亿	流通市值17.39亿	总股本4.83亿
成交额2.78万	换手率0.00%	流通股本3.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"瑞科生物-B","latestPrice":5.5,"timestamp":1764921373939,"preClose":5.45,"halted":0,"volume":5000,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.282559561082697,"marketStatus":"休市中","change":0.05,"latestTime":"12-05 15:56:13","open":5.62,"high":5.62,"low":5.5,"amount":27800,"amplitude":0.022018,"askPrice":5.5,"askSize":3000,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.4955436617623017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":5.45,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.081169,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"2588773780","title":"瑞科生物-B(02179)提名魏其芳及王静担任公司执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773780","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588773780?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:09","pubTimestamp":1764598180,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B 发布公告，公司董事会于2025年12月1日收到李布先生、陈青青女士及洪坤学博士的辞职报告。陈青青女士因其个人原因及计划倾注更多时间于其他工作，辞去公司执行董事、董事会提名委员会委员及联席公司秘书职务。彼等的辞职报告自送达董事会之日起生效。董事会于2025年12月1日召开的董事会会议上提名徐浩宇先生担任公司非执行董事，提名魏其芳先生及王静女士担任公司执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"1174682681","title":"江蘇瑞科生物（2179）更新2025年11月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1174682681","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174682681?lang=zh_cn&edition=full","pubTime":"2025-12-01 12:10","pubTimestamp":1764562236,"startTime":"0","endTime":"0","summary":"江蘇瑞科生物技術股份有限公司（股票代码：02179）于2025年12月1日发布2025年11月股份变动月报表。报告期内，公司已发行内资股为154,824,311股，非上市外资股为12,000,000股，H股为316,138,689股，三类股份数量均无增减变动，法定/注册股本总额维持人民币482,963,000元。\n根据月报显示，公司当月未有新增发行、购回、注销或库藏股活动，也未涉及任何股份期权、可换股票据或其他股权激励计划变动。截至2025年11月30日，公司股权结构及已发行股份总数保持稳定。\n公告显示，公司确认遵守香港联交所《上市规则》及相关法律规定。本次月报由公司董事刘勇签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"2584063836","title":"瑞科生物-B大跌5.27% 近日取得重组带状疱疹疫苗《药品生产许可证》增项","url":"https://stock-news.laohu8.com/highlight/detail?id=2584063836","media":"港美通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584063836?lang=zh_cn&edition=full","pubTime":"2025-11-17 14:36","pubTimestamp":1763361413,"startTime":"0","endTime":"0","summary":"11月17日14:21，瑞科生物-B股价大幅下跌5.27%。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗及相关佐剂成分的生产范围。本次增项标志着本集团在预防用生物制品领域的研发与生产能力实现进一步拓展，为后续药品上市注册奠定坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2583505876","title":"瞄准老龄化市场：瑞科生物重组带状疱疹疫苗生产许可增项获批，商业化提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505876","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583505876?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:22","pubTimestamp":1763122965,"startTime":"0","endTime":"0","summary":"11月14日，瑞科生物（02179）发布公告，近日公司获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗（CHO细胞）及相关佐剂成分的生产范围。本次增项生效日期为2025年11月5日，有效期至2026年11月14日，标志着公司在预防用生物制品领域的研发与生产能力实现进一步拓展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143565008996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2576510724","title":"瑞科生物-B：完成定向发行内资股的缴款及验资","url":"https://stock-news.laohu8.com/highlight/detail?id=2576510724","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576510724?lang=zh_cn&edition=full","pubTime":"2025-10-16 16:54","pubTimestamp":1760604840,"startTime":"0","endTime":"0","summary":"格隆汇10月16日丨瑞科生物-B公布，有关公司建议定向发行内资股及其相关事宜，以及关于定向发行内资股获中国证券监督管理委员会的批复。截至本公告日期，本次发行的募集资金已缴足，并已由根据中国法律设立的验资机构审验并出具验资报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016165916a6bcb9f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016165916a6bcb9f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2575044235","title":"瑞科生物-B10月13日主力净流出179.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2575044235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575044235?lang=zh_cn&edition=full","pubTime":"2025-10-13 16:15","pubTimestamp":1760343345,"startTime":"0","endTime":"0","summary":"10月13日, 瑞科生物-B股价跌0.88%，报收6.79元，成交金额196.2万元，换手率0.09%，振幅4.23%，量比9.21。瑞科生物-B今日主力资金净流出179.9万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.95%，主力资金累计净流出163.6万元；近20日主力资金累计净流出238.2万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162000a45d487c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162000a45d487c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2571343231","title":"瑞科生物-B09月30日主力净流出22.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2571343231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571343231?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:15","pubTimestamp":1759220151,"startTime":"0","endTime":"0","summary":"09月30日, 瑞科生物-B股价跌5.54%，报收7.16元，成交金额37.5万元，换手率0.02%，振幅5.01%，量比4.30。瑞科生物-B今日主力资金净流出22.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌4.53%，主力资金累计净流出22.7万元；近20日主力资金累计净流出74.5万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930162105a6a7fcf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930162105a6a7fcf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2567188441","title":"瑞科生物-B09月12日主力净流出51.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2567188441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567188441?lang=zh_cn&edition=full","pubTime":"2025-09-12 16:15","pubTimestamp":1757664951,"startTime":"0","endTime":"0","summary":"09月12日, 瑞科生物-B股价跌1.67%，报收7.67元，成交金额85.2万元，换手率0.04%，振幅5.00%，量比4.01。瑞科生物-B今日主力资金净流出51.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.27%，主力资金累计净流出51.8万元；近20日主力资金累计净流出15.5万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091216215195281d3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091216215195281d3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2563307506","title":"瑞科生物-B公布中期业绩 研发成本大幅增加46.0% 推进国际化战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2563307506","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563307506?lang=zh_cn&edition=full","pubTime":"2025-08-29 19:24","pubTimestamp":1756466672,"startTime":"0","endTime":"0","summary":"格隆汇8月29日丨瑞科生物-B发布公告，截至2025年6月30日止六个月，公司收入由截至2024年6月30日止六个月的无增加至人民币10.9百万元，该等增加主要是由于公司于本期授予知识产权许可产生收入。公司的研发成本由上年同期的人民币205.2百万元增加46.0%至截至2025年6月30日止六个月的人民币299.6百万元。截至本公告日期，公司的疫苗组合包括10余款候选疫苗。公司将采取病理学终点进行期中分析，满足条件后预期将在2026年提交BLA申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082919274795056be0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082919274795056be0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2563042091","title":"瑞科生物-B(02179)发布中期业绩，股东应占亏损3.41亿元，同比扩大36.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563042091","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563042091?lang=zh_cn&edition=full","pubTime":"2025-08-29 19:19","pubTimestamp":1756466380,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布2025年中期业绩，持续经营业务收入1089.9万元(人民币，下同)，上年同期：无;母公司拥有人应占亏损3.41亿元，同比扩大36.7%;每股基本亏损0.71元。收入同比增加主要是由于公司于本期授予知识产权许可产生收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1338800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"瑞科生物-B(02179)发布中期业绩，股东应占亏损3.41亿元，同比扩大36.7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2553479455","title":"瑞科生物-B07月21日主力净流入173.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553479455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553479455?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:15","pubTimestamp":1753085757,"startTime":"0","endTime":"0","summary":"07月21日, 瑞科生物-B股价涨5.79%，报收8.40元，成交金额624.9万元，换手率0.23%，振幅5.54%，量比51.07。瑞科生物-B今日主力资金净流入173.4万元，上一交易日主力净流出0万元。该股近5个交易日上涨8.95%，主力资金累计净流入173.4万元；近20日主力资金累计净流入512.9万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721170115a4590160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721170115a4590160&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2550524084","title":"不到进口一半！国产九价HPV疫苗定价来了，单支499元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524084","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550524084?lang=zh_cn&edition=full","pubTime":"2025-07-09 00:54","pubTimestamp":1751993651,"startTime":"0","endTime":"0","summary":"每经记者：陈星每经编辑：陈柯名,文多7月8日，首个国产九价HPV疫苗公布定价。另一边，按照目前公布的市场价格，默沙东旗下的进口九价HPV疫苗价格约为1318元/支。同时，针对外界关注的疫苗保护率问题，公司方面提到，九价HPV疫苗对相关持续感染的保护率超过98%。九价疫苗价格战或刚刚开始虽然万泰生物成为首个国产九价HPV疫苗的拥有者。但无论国内外厂家，都需要直面HPV疫苗接种高峰已经过去的现实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010047a43e7859&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010047a43e7859&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1981816686.USD","02179","BK1200","09633","BK1161","BK1589"],"gpt_icon":0},{"id":"2547506985","title":"瑞科生物与印度Biological E公司就重组九价HPV疫苗达成产品授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2547506985","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547506985?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:55","pubTimestamp":1751273716,"startTime":"0","endTime":"0","summary":"6月30日，瑞科生物宣布，公司与印度生物制品公司Biological E (下称“BE公司”)就重组九价HPV疫苗REC603签署产品授权合作协议。瑞科生物将向BE公司转移疫苗配制及分包装技术，并在适当时机转移原液生产技术。据协议，BE公司被独家授权在印度及由联合国儿童基金会（UNICEF）、泛美卫生组织（PAHO）主导的招标市场开发，生产及商业化重组九价HPV疫苗。目前，瑞科生物已收到合作预付款，并将按合作进度收取里程碑付款，以及基于一定比例年净销售额的特许权使用费。（界面新闻记者 陈杨）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630165517a4c63017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630165517a4c63017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2544258721","title":"瑞科生物-B(02179)：陈刚获委任为第二届董事会观察员","url":"https://stock-news.laohu8.com/highlight/detail?id=2544258721","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544258721?lang=zh_cn&edition=full","pubTime":"2025-06-20 17:59","pubTimestamp":1750413569,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布公告，于年度股东大会上，陈刚先生获委任为公司第二届董事会观察员。陈先生的任期自年度股东大会批准之日起，至第二届董事会任期届满之日止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2514870636","title":"瑞科生物-B(02179)定向发行内资股申请材料获中国证监会受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2514870636","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514870636?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:21","pubTimestamp":1740655278,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布公告，有关(其中包括)本公司建议定向发行内资股及其相关事宜已获临时股东大会审议批准的相关事宜。本公司于近日收到中国证监会出具的《中国证监会行政许可申请受理单》(受理序号：250162)。中国证监会依法对本公司提交的申请材料进行了审查，认为该申请材料齐全，决定对该行政许可申请予以受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2512964914","title":"瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512964914?lang=zh_cn&edition=full","pubTime":"2025-02-17 09:32","pubTimestamp":1739755975,"startTime":"0","endTime":"0","summary":"2025年02月17日早盘09时32分，瑞科生物-B股票出现波动，股价快速跳水9.88%。截至发稿，该股报8.210港元/股，成交量7500股，换手率0.00%，振幅9.77%。资金方面，该股资金流入0港元，流出5.881万港元。瑞科生物-B股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，科济药业-B、晶泰控股-P、基石药业-B涨幅较大，振幅较大的相关个股有科笛-B、瑞科生物-B、基石药业-B，振幅分别为9.88%、9.77%、7.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502170932569887fd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502170932569887fd26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2511471686","title":"瑞科生物-B盘中异动 急速下挫10.79%报8.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511471686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511471686?lang=zh_cn&edition=full","pubTime":"2025-02-14 10:15","pubTimestamp":1739499309,"startTime":"0","endTime":"0","summary":"2025年02月14日早盘10时15分，瑞科生物-B股票出现波动，股价急速下跌10.79%。截至发稿，该股报8.100港元/股，成交量6.8万股，换手率0.02%，振幅13.33%。瑞科生物-B股票所在的生物技术行业中，整体涨幅为2.67%。瑞科生物-B公司简介：江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。消息层面，截至10时15分，《瑞科生物-B新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理》资讯为影响瑞科生物-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141015099884ccc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141015099884ccc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2511513713","title":"瑞科生物九价HPV疫苗获新进展，股价竟萎靡不振？","url":"https://stock-news.laohu8.com/highlight/detail?id=2511513713","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511513713?lang=zh_cn&edition=full","pubTime":"2025-02-13 14:32","pubTimestamp":1739428349,"startTime":"0","endTime":"0","summary":"2月12日，港股的瑞科生物（02179.HK）发布公告称，公司近日收到国家药品监督管理局签发的受理通知书，同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c的临床试验申请。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/6430a70d-5888-476d-8512-761dc83ea647.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/6430a70d-5888-476d-8512-761dc83ea647.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67ad91fd5a7712d0652496cc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2511030417","title":"瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2511030417","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511030417?lang=zh_cn&edition=full","pubTime":"2025-02-13 00:26","pubTimestamp":1739377560,"startTime":"0","endTime":"0","summary":"瑞科生物－Ｂ(02179.HK) 公布，近日收到国家药品监督管理局通知书，同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c临床试验申请。REC604c是公司计划针对男性市场和升级市场开发的新型重组九价HPV疫苗。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416820/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","03347","159646","BK1141","BK1583","BK1576","02179"],"gpt_icon":0},{"id":"2510376095","title":"【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告，集团已于近日收到国家药品监督管理局签发的受理通知书，同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376095","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376095?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:55","pubTimestamp":1739364948,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK)发布公告，集团已于近日收到国家药品监督管理局签发的受理通知书，同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12205548120638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","02179","BK1161","159646","03347","BK1141","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.2132},{"period":"3month","weight":-0.2667},{"period":"6month","weight":-0.3552},{"period":"1year","weight":-0.321},{"period":"ytd","weight":-0.4211}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗，人乳头瘤病毒（HPV）疫苗管线包括重组HPV九价候选疫苗REC603，重组HPV二价候选疫苗REC601及REC602，重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071825},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044398},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06484},{"month":4,"riseRate":0.25,"avgChangeRate":-0.083572},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.013774},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016314},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033938},{"month":9,"riseRate":0.25,"avgChangeRate":-0.012227},{"month":10,"riseRate":0.5,"avgChangeRate":0.027812},{"month":11,"riseRate":0,"avgChangeRate":-0.140794},{"month":12,"riseRate":0.75,"avgChangeRate":0.12598}],"exchange":"SEHK","name":"瑞科生物-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞科生物-B,02179,瑞科生物-B股票,瑞科生物-B股票老虎,瑞科生物-B股票老虎国际,瑞科生物-B行情,瑞科生物-B股票行情,瑞科生物-B股价,瑞科生物-B股市,瑞科生物-B股票价格,瑞科生物-B股票交易,瑞科生物-B股票购买,瑞科生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}